It has been established previously that nephrotic hyperlipidemia is characterized by both an increase in lipid synthesis and a defect in removal of lipoproteins. The relationship between these defects and altered albumin metabolism is uncertain. One hypothesis is that hepatic lipogenesis increases in parallel with albumin synthesis. To test this hypothesis, albumin synthesis was increased in nephrotic rats fed an 8.5% protein diet (LPN) by increasing dietary protein to 40% (HPN). Proteinuria was modulated in half of the rats fed 40% protein by enalapril (HPE). Albumin synthesis was the same in both HPN and HPE, but proteinuria was reduced in HPE compared to HPN, and so were serum cholesterol and triglycerides (TG). To examine the effect of serum albumin on lipid clearance in the absence of proteinuria, plasma clearance of chylomicrons (CM) and VLDL was measured in Nagase analbuminemic rats (NAR) and found to be no different than in normal SD rats. When proteinuria was induced in NAR and in SD rats, a severe and identical defect in both CM and VLDL clearance was acquired in both groups and blood lipid levels were increased to a similar degree in both groups. Neither hyperlipidemia nor defective removal of lipoproteins from the circulation are linked to albumin synthesis or serum albumin concentration but result, at least in part, from proteinuria. Postheparin lipoprotein lipase (LPL) activity was reduced slightly in nephrotic animals compared to nonnephrotic controls, but the most striking finding was a highly significant decrease in postheraprin LPL activity in normal NAR compared to SD rats (P less than 0.001), suggesting that reduced LPL activity is not responsible for reduced clearance of CM and VLDL in nephrotic rats.
R W Davies, I Staprans, F N Hutchison, G A Kaysen
Title and authors | Publication | Year |
---|---|---|
Albumin is an interface between blood plasma and cell membrane, and not just a sponge.
van de Wouw J, Joles JA |
Clinical Kidney Journal | 2021 |
Kidney-derived PCSK9—a new driver of hyperlipidemia in nephrotic syndrome?
F Artunc |
Kidney International | 2020 |
Kidney Lipidomics by Mass Spectrometry Imaging: A Focus on the Glomerulus
I Abbas, M Noun, D Touboul, D Sahali, A Brunelle, M Ollero |
International journal of molecular sciences | 2019 |
Endocrine Disorders in Kidney Disease: Diagnosis and Treatment
CM Rhee, K Kalantar-Zadeh, GA Brent |
2019 | |
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment
S Agrawal, JJ Zaritsky, A Fornoni, WE Smoyer |
Nature Reviews Nephrology | 2017 |
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences
ND Vaziri |
Kidney International | 2016 |
Treatment of Hyperlipidemia Changes With Level of Kidney Function—Rationale
S Ananthakrishnan, GA Kaysen |
Advances in Chronic Kidney Disease | 2016 |
Dyslipidemias: Pathophysiology, Evaluation and Management
A Garg |
2015 | |
Nutritional Management of Renal Disease
A Molfino, BR Don, GA Kaysen |
Nutritional Management of Renal Disease | 2013 |
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich |
Seldin and Giebisch's The Kidney | 2013 |
Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome
S Han, ND Vaziri, P Gollapudi, V Kwok, H Moradi |
American journal of translational research | 2013 |
Brenner and Rector's The Kidney
C Brugnara, KU Eckardt |
Brenner and Rector's The Kidney | 2012 |
Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels
L Wang, GC Shearer, MS Budamagunta, JC Voss, A Molfino, GA Kaysen |
Kidney International | 2012 |
Lack of plasma albumin impairs intravascular lipolysis and explains the associated free fatty acids deficiency and hypertriglyceridemia
TR Figueira, AE Vercesi, HC Oliveira |
Lipids in Health and Disease | 2010 |
Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria
S Bell, J Cooney, CJ Packard, M Caslake, CJ Deighan |
Atherosclerosis | 2009 |
Nutrition in Kidney Disease
LD Byham-Gray, GM Chertow, JD Burrowes |
2008 | |
Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus
T Sarkissian, J Beyene, B Feldman, B McCrindle, ED Silverman |
Arthritis & Rheumatism | 2007 |
Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion
GC Shearer, GA Kaysen |
Kidney International | 2006 |
Regulation of Epithelial Sodium Channel in Puromycin Aminonucleoside-Induced Unilateral Experimental Nephrotic Syndrome in Normal and Analbuminemic Nagase Rats
Z Yu, M Schumacher, BM Frey, FJ Frey, B Vogt |
Nephron Physiology | 2005 |
Statins in nephrotic syndrome: A new weapon against tissue injury
M Buemi, L Nostro, E Crascì, A Barillà, V Cosentini, C Aloisi, T Sofi, S Campo, N Frisina |
Medicinal Research Reviews | 2005 |
Effects of gender on hepatic HMG-CoA reductase, cholesterol 7α-hydroxylase, and LDL receptor in hereditary analbuminemia
Y Shin, ND Vaziri, N Willekes, CH Kim, JA Joles |
American journal of physiology. Endocrinology and metabolism | 2005 |
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome
ND Vaziri, CH Kim, D Phan, S Kim, K Liang |
Kidney International | 2004 |
Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL
GC Shearer, WG Couser, GA Kaysen |
Kidney International | 2004 |
Effect of Lovastatin on lipid peroxidation and total antioxidant concentrations in hemodialysis patients
H Argani, A Ghorbani, N Rashtchizade, M Rahbaninobar |
Lipids in Health and Disease | 2004 |
Molecular mechanisms of lipid disorders in nephrotic syndrome
ND Vaziri |
Kidney International | 2003 |
Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome
ND Vaziri, K Liang |
Kidney International | 2002 |
Comorbidity and Cardiovascular Risk Factors in Patients With Chronic Kidney Disease
J Paparello, A Kshirsagar, D Batlle |
Seminars in Nephrology | 2002 |
Improving Prognosis for Kidney Disorders
MM Avram |
2002 | |
Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome1
GC Shearer, FT Stevenson, DN Atkinson, H Jones, I Staprans, GA Kaysen |
Kidney International | 2001 |
Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis
GC Shearer, WG Couser, GA Kaysen |
American Journal of Kidney Diseases | 2001 |
Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms
GC Shearer, GA Kaysen |
American Journal of Kidney Diseases | 2001 |
Plasma protein synthesis in patients with low-grade nephrotic proteinuria
M Zanetti, R Barazzoni, G Garibotto, G Davanzo, C Gabelli, E Kiwanuka, A Piccoli, M Tosolini, P Tessari |
American journal of physiology. Endocrinology and metabolism | 2001 |
Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome
ND Vaziri, K Liang, JS Parks |
American journal of physiology. Renal physiology | 2001 |
Estrogen effects on triglyceride metabolism in analbuminemic rats
GC Shearer, JA Joles, H Jones, RL Walzem, GA Kaysen |
Kidney International | 2000 |
Early Mechanisms of Renal Injury in Hypercholesterolemic or Hypertriglyceridemic Rats
JA Joles, U Kunter, U Janssen, W Kriz, TJ Rabelink, HA Koomans, J Floege |
Journal of the American Society of Nephrology : JASN | 2000 |
New insights into lipid metabolism in the nephrotic syndrome
GA Kaysen, MG de der Velden |
Kidney International | 1999 |
Lipid-lowering therapy in membranous nephropathy
M Haas, D Kerjaschki, G Mayer |
Kidney International | 1999 |
Lipopheresis in the nephrotic syndrome
C Brunton, Z Varghese, JF Moorhead |
Kidney International | 1999 |
Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure
HJ Milionis, MS Elisaf, A Tselepis, E Bairaktari, SA Karabina, KC Siamopoulos |
American Journal of Kidney Diseases | 1999 |
The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1
M Zaiou, N Azrolan, T Hayek, H Wang, L Wu, M Haghpassand, B Cizman, MP Madaio, J Milbrandt, JB Marsh, JL Breslow, EA Fisher |
Journal of Clinical Investigation | 1998 |
Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis
MG de der Velden, GA Kaysen, HA Barrett, F Stellaard, MM Gadellaa, HA Voorbij, DJ Reijngoud, TJ Rabelink |
Kidney International | 1998 |
The Nephrotic Syndrome
SR Orth, E Ritz |
New England Journal of Medicine | 1998 |
Combination of vasopressin and angiotensin inhibition in experimental focal glomerulosclerosis
I KURIHARA, T SAITO, K OBARA, M HIRAI, J SOMA, H SATO, K ABE |
Nephrology | 1997 |
Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD
WS Yang, WK Min, JS Park, SB Kim |
American Journal of Kidney Diseases | 1997 |
Gene expression of lipoprotein lipase in experimental nephrosis
K Liang, ND Vaziri |
Journal of Laboratory and Clinical Medicine | 1997 |
Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine
JA Joles, N Willekes-Koolschijn, HA Koomans |
Kidney International | 1997 |
Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS
WN Suki, SG Massry |
1997 | |
Lipoprotein Kinetics in Patients With Analbuminemia: Evidence for the Role of Serum Albumin in Controlling Lipoprotein Metabolism
C Maugeais, S Braschi, K Ouguerram, P Maugeais, P Mahot, B Jacotot, D Darmaun, T Magot, M Krempf |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Role of Lipoprotein-Bound NEFAs in Enhancing the Specific Activity of Plasma CETP in the Nephrotic Syndrome
S Braschi, D Masson, G Rostoker, E Florentin, A Athias, C Martin, B Jacotot, P Gambert, C Lallemant, L Lagrost |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity
J Joven, X Clivillé, J Camps, E Espinel, J Simó, E Vilella, A Oliver |
Clinical chemistry | 1997 |
The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia
J Joven, E Espinel, JM Simó, E Vilella, J Camps, A Oliver |
Atherosclerosis | 1996 |
Will angiotensin II receptor antagonists be renoprotective in humans?
I Ichikawa |
Kidney International | 1996 |
The serum lathosterol to cholesterol ratio, an index of cholesterol synthesis, is not elevated in patients with glomerular proteinuria and is not associated with improvement of hyperlipidemia in response to antiproteinuric treatment
RP Dullaart, RT Gansevoort, WJ Sluiter, D Zeeuw, PE de Jong |
Metabolism | 1996 |
Plasma triglyceride levels are higher in nephrotic than in analbuminemic rats despite a similar increase in hepatic triglyceride secretion
JA Joles, C Bijleveld, A Tol, MJ Geelen, HA Koomans |
Kidney International | 1995 |
Metabolism of low density lipoproteins in nephrotic dyslipidemia: Comparison of hypercholesterolemia alone and combined hyperlipidemia
GL Vega, RD Toto, SM Grundy |
Kidney International | 1995 |
Effect of oncotic pressure on apolipoprotein A-I metabolism in the rat
GA Kaysen, E Hoye, H Jones, A Tol, JA Joles |
American Journal of Kidney Diseases | 1995 |
Ovariectomy decreases plasma triglyceride levels in analbuminaemic rats by lowering hepatic triglyceride secretion
JA Joles, C Bijleveld, A Tol, MJ Geelen, HA Koomans |
Atherosclerosis | 1995 |
Selected Aspects of ACE Inhibitor Therapy for Patients with Renal Disease: Impact on Proteinuria, Lipids and Potassium
T Keilani, W Schlueter, D Batlle |
The Journal of Clinical Pharmacology | 1995 |
Albumin and transferrin synthesis are increased in H4 cells by serum from analbuminemic or nephrotic rats
X Sun, GA Kaysen |
Kidney International | 1994 |
Nagase analbuminemic rats have faster plasma triacylglycerol and VLDL synthesis rates
S Catanozzi, JC Rocha, ER Nakandakare, HC Oliveira, EC Quintão |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1994 |
Extrarenal Complications of the Nephrotic Syndrome
RC Harris, N Ismail |
American Journal of Kidney Diseases | 1994 |
Lipid Abnormalities in the Nephrotic Syndrome: Causes, Consequences, and Treatment
DC Wheeler, DB Bernard |
American Journal of Kidney Diseases | 1994 |
Synergistic Effects of Fish Oil Diet and Dimethylthiourea in Acute Adriamycin Nephrosis
LS Milner, S Wei, P Kazakoff, L Watkins, MT Houser |
The American Journal of the Medical Sciences | 1994 |
Reduction of hyperlipidemia and proteinuria without growth retardation in nephritic rats by amino acids-fortified low casein diets
K Fujisawa, K Yagasaki, R Funabiki |
The Journal of Nutritional Biochemistry | 1994 |
Hyperlipidemia in childhood nephrotic syndrome
MA Thabet, JR Salcedo, JC Chan |
Pediatric Nephrology | 1993 |
Lipid synthesis and apolipoprotein gene expression in hepatocytes in primary culture from (puromycin-induced) nephrotic rats
SE Boustani, A Ribeiro, B Janvier, C Loriette, R Bensman, P Druet, J Chambaz, M Mangeney |
European Journal of Clinical Investigation | 1993 |
Lipoprotein(a) in nephrotic syndrome
P Stenvinkel, L Berglund, O Heimbürger, E Pettersson, A Alvestrand |
Kidney International | 1993 |
Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells
A Krämer, M Nauck, H Pavenstädt, S Schwedler, H Wieland, P Schollmeyer, C Wanner |
Kidney International | 1993 |
Electrophoretic Analysis of Serum and Urinary Proteins in Rats with Aminonucleoside-Induced Nephrotic Syndrome
J Pedraza-Chaverri, P Calderón, C Cruz, JC Peña |
Renal Failure | 1993 |
Metabolic effects of converting enzyme inhibitors: Focus on the reduction of cholesterol and lipoprotein(a) by fosinopril
W Schlueter, T Keilani, DC Batlle |
The American Journal of Cardiology | 1993 |
Defective Lipolysis Persists in Hearts of Rats With Heymann Nephritis in the Absence of Nephrotic Plasma
GA Kaysen, XM Pan, WG Couser, I Staprans |
American Journal of Kidney Diseases | 1993 |
Activity of Serum Enzymes in Puromycin Aminonucleoside-Induced Nephrotic Syndrome
J Pedraza-Chaverri, C Cruz, E Tapia, JC PeÑA |
Renal Failure | 1992 |
Plasma lipoproteins and cholesterol metabolism in Yoshida rats: An animal model of spontaneous hyperlipemia
S Fantappiè, AL Catapano, M Cancellieri, L Fasoli, ED Fabiani, M Bertolini, E Bosisio |
Life Sciences | 1992 |
Nutritional Management of Nephrotic Syndrome
GA Kaysen |
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation | 1992 |
Lipid abnormalities in renal disease
G Appel |
Kidney International | 1991 |
Influence of age-related nephropathy on plasma lipoproteins of the aging rat
S Calandra, P Tarugi |
Aging clinical and experimental research | 1991 |
Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome
P Tarugi, S Nicolini, L Albertazzi, S Calandra, P Salvati, C Ferti, C Patrono |
Journal of lipid research | 1991 |
Hyperlipoproteinemia in Nagase analbuminemic rats: effects of pravastatin on plasma (apo)lipoproteins and lecithin:cholesterol acyltransferase activity
AV Tol, EH Jansen, HA Koomans, JA Joles |
Journal of lipid research | 1991 |